Buscar
Mostrando ítems 31-40 de 3034
Central nervous system commitment in Chagas disease
(Frontiers Media, 2023)
Should mast cells be considered therapeutic targets in multiple sclerosis?
(2020-11-01)
Mast cells are immune cells of the myeloid lineage that are found throughout the body, including the central nervous system. They perform many functions associated with innate and specific immunity, angiogenesis, and ...
Trypanosoma cruzi: experimental parasitism in the central nervous system of albino mice
(Springer-Verlag 2012, 2014)
Dengue in Patients with Central Nervous System Manifestations, Brazil
(Centers for Disease Control and Prevention, 2017)
A new method to measure autophagy flux in the nervous system
(Taylor and Francis Inc., 2014)
A current need in the neuroscience field is a simple method to monitor autophagic activity in vivo in neurons. Until very recently, most reports have been based on correlative and static determinations of the expression ...
Differential alterations in the activity of matrix metalloproteinases within the nervous tissue of dogs in distinct manifestations of visceral leishmaniasis
(Elsevier B.V., 2010-08-15)
Canine visceral leishmaniasis is an important emerging disease with a multitude of clinical symptoms, including neurological alterations. Matrix metalloproteinases (MMP) are proteases implicated with the extracellular ...
Differential alterations in the activity of matrix metalloproteinases within the nervous tissue of dogs in distinct manifestations of visceral leishmaniasis
(Elsevier B.V., 2010-08-15)
Canine visceral leishmaniasis is an important emerging disease with a multitude of clinical symptoms, including neurological alterations. Matrix metalloproteinases (MMP) are proteases implicated with the extracellular ...
Peptide prodrugs for the treatment of CNS disorders: A perspective for new drugs
(2014-01-01)
The treatment of central nervous system (CNS) diseases is a major challenge. The presence of the barrier intended to protect the brain from unwanted molecules also impairs the efficacy of CNS-targeted drugs. The discovery ...
Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs
(Bentham Science Publ Ltd, 2014-01-01)
The treatment of central nervous system (CNS) diseases is a major challenge. The presence of the barrier intended to protect the brain from unwanted molecules also impairs the efficacy of CNS-targeted drugs. The discovery ...
Vasculitis primaria del sistema nervioso central, diagnóstico diferencial de demencia subaguda: Caso clínico
(Sociedad Médica de Santiago, 2009)